CORDIS
EU research results

CORDIS

English EN
Collaborative European effort to Develop Diabetes Diagnostics

Collaborative European effort to Develop Diabetes Diagnostics

Objective

CEED3 (Collaborative European Effort to Develop Diabetes Diagnostics) has as its central objective, the development of diagnostic tools to differentiate specific subgroups of diabetic patients to allow individualisation of patient care. CEED3 will achieve this by integrating basic science findings from animal models, cell studies, and large scale genetic studies with clinical observations and testing of patients’ phenotype. The development of diabetes diagnostic tools will involve a clearly defined process of discovery of potential novel genetic and non-genetic biomarkers, validation within test and population based data samples, development of a clinical application and then dissemination of this application. The areas of focus for the diabetes diagnostics will be three areas where there is potential for considerable improvement in care and reduction in the burden of diabetes: the identification of patients with specific subgroups of monogenic diabetes, the identification of non diabetic and diabetic subjects with initial pancreatic beta-cell dysfunction at high risk of rapidly deteriorating glycaemia and the detection of diabetic patients at increased risk of vascular complications. For each of these patient groups the identification of the subgroups will result in improved clinical care by allowing treatment to be tailored for the individual patient. Therefore, the goal of this proposal is to make a rapid translation from scientific discoveries to improved care for diabetic patients. CEED3 has assembled the best researchers, clinical samples and technical expertise in Europe to realise this goal.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

THE UNIVERSITY OF EXETER

Address

The Queen'S Drive Northcote House
Ex4 4qj Exeter

United Kingdom

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 574 672

Administrative Contact

Enda Clarke (Dr.)

Participants (11)

Sort alphabetically

Sort by EU Contribution

Expand all

INTEGRAGEN SA

France

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

United Kingdom

EU Contribution

€ 367 666

LUNDS UNIVERSITET

Sweden

EU Contribution

€ 487 666

FUNDACIO CLINIC PER A LA RECERCA BIOMEDICA

Spain

EU Contribution

€ 196 363

UNIVERSITE LIBRE DE BRUXELLES

Belgium

EU Contribution

€ 196 363

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH

Switzerland

EU Contribution

€ 196 363

PROTEOMIKA SL

Spain

EU Contribution

€ 252 576

SAMFUNDET FOLKHALSAN I SVENSKA FINLAND RF

Finland

EU Contribution

€ 110 000

TECHNISCHE UNIVERSITAET DRESDEN

Germany

EU Contribution

€ 91 666

COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES

France

EU Contribution

€ 211 665

UNIWERSYTET JAGIELLONSKI

Poland

EU Contribution

€ 315 000

Project information

Grant agreement ID: 223211

Status

Closed project

  • Start date

    1 December 2008

  • End date

    30 November 2012

Funded under:

FP7-HEALTH

  • Overall budget:

    € 3 830 004

  • EU contribution

    € 3 000 000

Coordinated by:

THE UNIVERSITY OF EXETER

United Kingdom

This project is featured in...